6-Gingerol is originally found in species of Zingiber; it that exhibits antiemetic, antacid, anticancer, anti-inflammatory, anti-obesity, antihypertensive, anti-asthma, analgesic, and antinociceptive activities. 6-Gingerol inhibits 5-HT3 receptors and K2P 3.1 (TASK-1), K2P 9.1 (TASK-3), and K2P 18.1 (TRESK) K+ channels. 6-Gingerol also activates transient receptor potential vanilloid 1 (TRPV1) channels, decreasing allodynia and hyperalgesia in vivo. In other models, 6-gingerol inhibits the angiotensin II type 1 (AT-II) receptor, decreasing blood pressure. This compound also induces G2/M phase cell cycle arrest and apoptosis, inhibits mitochondrial respiration, increases oxidative stress and ROS production, and inhibits proliferation in myeloid leukemia cells. Additionally, 6-gingerol inhibits IL-1?-induced production of COX-2, NF-?B, IL-6, and IL-8, suppressing hepatic inflammation in vitro. 6-gingerol also inhibits rosiglitazone-induced adipogenesis, decreasing triglyceride levels and oil droplet sizes and downregulating expression of PPAR?. This compound also attenuates airway hyperresponsiveness in animal models.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...


































